ArticleScientific reports2026

Fc engineering of a fully humanized anti-CD147 monoclonal antibody enhances ADCC against T-cell acute lymphoblastic leukemia and T-lymphoblastic lymphoma.

Zaw Ye Htet et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.